Olmesartan Medoxomil
Product Images NDC 42571-203

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Olmesartan Medoxomil (NDC 42571-203). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Micro Labs Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Olmesartan Lbla

Label for Olmesartan Medoxomil 5 mg tablets, USP. The label states each film-coated tablet contains Olmesartan Medoxomil USP 5 mg. It includes storage instructions and dosage directions referencing the package insert. The label indicates a package size of 30 tablets. Manufactured by Micro Labs Limited, Goa, India, and for Micro Labs USA Inc., Somerset, NJ.*

FDA Label Image

Olmesartan Lblb

Label for Olmesartan Medoxomil Tablets USP 20 mg, a film-coated tablet manufactured by Micro Labs Limited. The label shows a package count of 30 tablets and includes storage instructions at 20° to 25°C (68° to 77°F). It also displays NDC 42571-202-30 and indicates the product is Rx only. Manufacturer details include Micro Labs Limited in Goa, India, and Micro Labs USA Inc. in Somerset, NJ.*

FDA Label Image

Olmesartan Lblc

Packaging label for Olmesartan Medoxomil Tablets, USP 40 mg, containing 30 tablets. The label includes storage instructions to keep at 20° to 25°C, highlights prescription-only status, and lists Micro Labs Limited in Goa, India, as manufacturer, with Micro Labs USA Inc. as the U.S. manufacturer. The label also features barcode and 2D matrix code information.*

FDA Label Image

Fig 1 (Olmesartanfig1)

A line graph depicting the reduction in blood pressure (BP) in mmHg with increasing doses of Olmesartan Medoxomil (mg). The graph includes two lines: one for systolic BP reduction (circle markers) and one for diastolic BP reduction (triangle markers). Both BP parameters show a dose-related increase in reduction, with systolic BP reduction consistently higher than diastolic at all doses shown.*

FDA Label Image

Structure (Olmesartanstrc)

Chemical structure diagram of Olmesartan Medoxomil showing its molecular configuration with labeled chemical groups and bonds.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.